Delhi toxic air triggers exit of Akums Drugs and Pharma Finance head

Responding to the resignation, Chief Financial Officer Sumeet Sood expressed regret over the decision but acknowledged the health concerns involved.

“Though we regret your decision, given your health issues we will not be able to persuade you. As desired, we will formally relieve you on December 31, 2025,” Sood said.

The development comes amid growing concern over Delhi’s air pollution and its impact on public health, with this resignation highlighting how environmental conditions are increasingly influencing corporate decisions as well.

Akums Drugs & Pharmaceuticals Ltd is a pharmaceutical contract development and manufacturing organization (“CDMO”) offering a comprehensive range of pharmaceutical products and services in India and overseas. The own the intellectual property for the manufacturing processes of several of its formulations, and its core business is focused on providing end-to-end product development and manufacturing solutions to clients. The company has presence in over 60 countries worldwide. Over 12% of all domestically used medications are produced by Akums in almost all therapeutic segments.